Assignee
MOMOTARO GENE INC
JP·2 granted patents·3 pending applications·2 citations·filing 2013–2021
Top patents by PatentIndex Score
5 records- 0179US11484592B2Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitorMOMOTARO GENE INC·Filed 2017·Granted Nov 1, 2022·2 cites·2 claims
- 0253US2023310653A1THERAPEUTIC AGENT FOR EGFR GENE MUTATION-POSITIVE LUNG CANCER COMPRISING REIC/Dkk-3 GENEMOMOTARO GENE INC·Filed 2021·Application pending·0 cites
- 0347US11951182B2Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitorMOMOTARO GENE INC·Filed 2019·Granted Apr 9, 2024·0 cites·6 claims
- 0447US2022280601A1METHOD FOR TREATMENT OF HEPATIC CANCER USING REIC/Dkk-3 GENE IN COMBINATION WITH ANTI-TUMOR AGENTMOMOTARO GENE INC·Filed 2020·Application pending·0 cites
- 0545US2014056945A1Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activityMOMOTARO GENE INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MOMOTARO GENE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →